Vensana Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 9
Rounds per year 2.50
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 1
Key employees 2

Areas of investment

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Health Diagnostics
Summary

Vensana Capital appeared to be the VC, which was created in 2018.

We can highlight the next thriving fund investment areas, such as Medical Device, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vesper Medical, Intact Vascular. The fund has exact preference in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Vensana Capital, startups are often financed by Quaker Partners, New Enterprise Associates, H.I.G. BioHealth Partners. The meaningful sponsors for the fund in investment in the same round are Quaker Partners, New Enterprise Associates, H.I.G. BioHealth Partners.

The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Vensana Capital:
Typical Co-investors
Vensana Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Vensana Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anwin Capital China, Guangdong, Shenzhen
Cathay Capital Beijing, Beijing, China
Chiesi Pharmaceuticals Emilia-Romagna, Italy, Parma
Hangzhou Ruide Design Binjiang, China, Jiangxi
Harmony Auto Holding China, Henan, Zhengzhou
Intelsat Luxembourg, Luxembourg
Jiantou Jiachi Touzi China, Hongkou District
Kunying Capital -
LBS Technologies -
Living House Chiba Prefecture, Japan, Tateyama
Manifest Investment Partners Belvedere Tiburon, California, United States
Monogram Capital Partners Beverly Hills, California, United States
Muehlstein -
NaHCO3 California, Los Angeles, United States
Nite Capital Management Illinois, Libertyville, United States
Shougang Group Co, Ltd. Beijing, Beijing, China
The Engine Cambridge, Massachusetts, United States
Vencorp Partners Luxembourg, Luxembourg
Yuku Guoji -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Apella Technology

Health Care
Medical
Wellness
$21M20 Dec 2021 San Francisco, California, United States

Cleerly

Apps
Artificial Intelligence
Education
Health Care
Information Technology
Medical
$43M21 Jun 2021 New York, New York, United States

GPB Scientific

Biotechnology
Health Care
Health Diagnostics
Medical Device
$18M27 May 2021 Richmond, Virginia, United States

Personal Genome Diagnostics

Analytics
Bioinformatics
Biotechnology
Genetics
Health Diagnostics
Medical
$103M10 Feb 2021 Baltimore, Maryland, United States

Spyglass Ophthalmics

Health Care
Health Diagnostics
Medical Device
Wellness
$27M07 Jan 2021 Mission Viejo, California, United States

Relievant Medsystems

Biotechnology
Health Care
Medical
$70M29 Oct 2020 Minneapolis, Minnesota, United States

CVRx

Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$50M07 Jul 2020 Minneapolis, Minnesota, United States

GPB Scientific

Biotechnology
Health Care
Health Diagnostics
Medical Device
$25M27 Mar 2020 Richmond, Virginia, United States

Intact Vascular

Health Care
Manufacturing
Medical Device
Pharmaceutical
$25M30 May 2019 Radnor Township, Pennsylvania, United States
News
Cleerly Raises $43M in Series B Funding

– Cleerly, a NYC-based company creating a new standard of care for heart disease, launched with $43m in Series B funding.
– The round was led by Vensana Capital with participation from LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures, and existing investors.
– The company intends to use the funds to scale its commercial reach, expand operational capabilities and strategic partnerships, and continue to grow its focus on research and development.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Vensana Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: